Pneumococcal 13-valent conjugate vaccine

Keep track of any and all side effects your child has after receiving this vaccine. When the child receives a booster dose, you will need to tell the doctor if the previous shot caused any side effects.

You should not receive this vaccine if you ever had a severe allergic reaction to a pneumococcal or diphtheria vaccine.

Before your child receives this vaccine, tell your doctor if the child was born prematurely.

To make sure you or your child can safely receive this vaccine, tell your doctor if you or your child have any of these other conditions:

• a bleeding or blood clotting disorder such as hemophilia or easy bruising; or

• a weak immune system caused by disease, bone marrow transplant, or by using certain medicines or receiving cancer treatments.

You can still receive a vaccine if you have a minor cold. In the case of a more severe illness with a fever or any type of infection, wait until you get better before receiving this vaccine.

Contact your doctor if your child will miss a booster dose or gets behind schedule. The next dose should be given as soon as possible. There is no need to start over.

Be sure your child receives all recommended doses of this vaccine. If your child does not receive the full series of vaccines, he or she may not be fully protected against the disease.

An overdose of this vaccine is unlikely to occur.

Usual Adult Dose for Pneumococcal Disease Prophylaxis:

50 years and older:
0.5 mL, IM, once

Usual Pediatric Dose for Pneumococcal Disease Prophylaxis:

6 weeks to 5 years:
4 doses: 0.5 mL, IM, at 2 months, 4 months, 6 months, and 12 to 15 months


Unvaccinated Children 7 months through 5 years:

-Aged 7 to 11 months at first dose: a total of three 0.5 mL doses, IM
--Give the first 2 doses at least 4 weeks apart.
--Give the third dose after the one year birthday, at least 2 months after the second dose.

-Aged 12 to 23 months at first dose: a total of two 0.5 mL doses, IM
--Give the doses at least 2 months apart.

-Aged 24 months to 5 years at first dose: one 0.5 mL dose, IM


6 to 17 years:
0.5 mL, IM, once, at least 8 weeks after any previous pneumococcal vaccine

50 years and older:
0.5 mL, IM, once

Safety has not been established during pregnancy; use during pregnancy only if clearly needed. AU TGA pregnancy category: B2 US FDA pregnancy category: B

Animal studies showed no fetal harm or impairment of fertility; antibodies against vaccine serotypes were detected in the fetuses and pups. There are no controlled data in human pregnancy. AU TGA pregnancy category B2: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.